Search research articles
Contact Us
Filters
Showing results (31-40 of 84) with videos related to
Page
of 9
Sort By:
Clinical Rheumatology
|
February 4, 2015
A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F))
Anna Moverley, Laura Coates, Helena Marzo-Ortega, et al.
Surgical Endoscopy
|
February 27, 2014
Electrostatic precipitation is a novel way of maintaining visual field clarity during laparoscopic surgery: a prospective double-blind randomized controlled pilot study
James Ansell, Neil Warren, Pete Wall, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 27, 2025
Derivation of Meaningful Change Thresholds for European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-LC13 in Patients With Small Cell Lung Cancer
Franziska Dirnberger, Jessie Wang, Bellinda King-Kallimanis, et al.
European Journal of Haematology
|
August 25, 2019
Estimation of minimally important differences and responder definitions for EORTC QLQ-MY20 scores in multiple myeloma patients
Kate Sully, Andrew Trigg, Nicola Bonner, et al.
Journal of Patient-Reported Outcomes
|
August 25, 2020
What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?
Rachael Lawrance, Evgeny Degtyarev, Philip Griffiths, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 24, 2010
Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial
Galina Velikova, Ada Keding, Clare Harley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 29, 2021
A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions
James W Shaw, Bryan Bennett, Andrew Trigg, et al.
Journal of Patient-Reported Outcomes
|
December 18, 2024
Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: targeted literature review and best practice recommendations
Kim Cocks, Bellinda L King-Kallimanis, Joel Sims, et al.
Blood Cancer Journal
|
February 24, 2019
Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma
Heinz Ludwig, Philippe Moreau, Meletios A Dimopoulos, et al.
Schizophrenia Research
|
April 12, 2026
Structural and construct validity assessment of the schizophrenia cognition rating scale (SCoRS) using data from three international phase 3 randomized controlled trials (CONNEX programme)
Ben Pascoe, Kim Cocks, Nathan Clarke, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 84) with videos related to
Sort By:
Page
of 9
Clinical Rheumatology
|
February 4, 2015
A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F))
Anna Moverley, Laura Coates, Helena Marzo-Ortega, et al.
Surgical Endoscopy
|
February 27, 2014
Electrostatic precipitation is a novel way of maintaining visual field clarity during laparoscopic surgery: a prospective double-blind randomized controlled pilot study
James Ansell, Neil Warren, Pete Wall, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 27, 2025
Derivation of Meaningful Change Thresholds for European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-LC13 in Patients With Small Cell Lung Cancer
Franziska Dirnberger, Jessie Wang, Bellinda King-Kallimanis, et al.
European Journal of Haematology
|
August 25, 2019
Estimation of minimally important differences and responder definitions for EORTC QLQ-MY20 scores in multiple myeloma patients
Kate Sully, Andrew Trigg, Nicola Bonner, et al.
Journal of Patient-Reported Outcomes
|
August 25, 2020
What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?
Rachael Lawrance, Evgeny Degtyarev, Philip Griffiths, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 24, 2010
Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: secondary outcomes of a randomised controlled trial
Galina Velikova, Ada Keding, Clare Harley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
October 29, 2021
A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions
James W Shaw, Bryan Bennett, Andrew Trigg, et al.
Journal of Patient-Reported Outcomes
|
December 18, 2024
Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: targeted literature review and best practice recommendations
Kim Cocks, Bellinda L King-Kallimanis, Joel Sims, et al.
Blood Cancer Journal
|
February 24, 2019
Health-related quality of life in the ENDEAVOR study: carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma
Heinz Ludwig, Philippe Moreau, Meletios A Dimopoulos, et al.
Schizophrenia Research
|
April 12, 2026
Structural and construct validity assessment of the schizophrenia cognition rating scale (SCoRS) using data from three international phase 3 randomized controlled trials (CONNEX programme)
Ben Pascoe, Kim Cocks, Nathan Clarke, et al.
Page
of 9